RxDoctor Payments Data

Stephanie Prenatt

Physician Assistant · Meadville, PANPI 1922382019

Payments from drug & device makers

$1,530in general payments, 2019–2025

Across 85 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$209
  • Lilly USA, LLC$185
  • AbbVie$179
  • Astellas Pharma US Inc$140
  • GSK$138
  • AstraZeneca$123
  • plus $556 from 17 others

What the payments were for

  • Food & beverage$1,51399%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,530 in reported general payments places this provider in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide139$132,366
EliquisApixaban110$76,106
JardianceEmpagliflozin87$69,039
XareltoRivaroxaban53$45,978
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$45,713
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr91$43,871
TradjentaLinagliptin49$40,446
OzempicSemaglutide39$36,041
MyrbetriqMirabegron52$34,878
LinzessLinaclotide35$21,747
JanuviaSitagliptin Phosphate20$16,736
RybelsusSemaglutide17$16,389
Stiolto RespimatTiotropium Br/Olodaterol Hcl23$15,586
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,454
FarxigaDapagliflozin Propanediol20$12,751

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$185$132,366139 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$64$125,072159 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$138$106,015185 claims
PfizerEliquis, Protonix$82$85,891122 claims
Novo NordiskOzempic, Rybelsus$209$52,43056 claims
Johnson & JohnsonXarelto$15$45,97853 claims
Astellas Pharma US IncMyrbetriq$140$34,87852 claims
AstraZenecaBreztri Aerosphere, Farxiga$123$27,20543 claims
AbbVieLinzess$179$21,74735 claims
MerckJanuvia$21$16,73620 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$16$6,72112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Meadville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →